InvestorsHub Logo
Followers 1609
Posts 120134
Boards Moderated 3
Alias Born 07/09/2003

Re: RIGATONI post# 379642

Monday, 04/01/2024 3:19:27 PM

Monday, April 01, 2024 3:19:27 PM

Post# of 380406
Edward E Jacobs Jr.
CEO

BDPT .0008



Dr. Edward E. Jacobs, Jr., a graduate of Princeton and Harvard Medical School, is a biotechnology consultant with over 25 years experience in biopharmaceutical and medical device development, as well as, 35 years of teaching and direct patient care. His drug development experience involved animal and human trials, including medical support for FDA and international regulatory affairs, strategic planning and investor relations. Dr. Jacobs received surgical training in Boston and held research positions at the National Institutes of Health, and at St. Thomas' Hospital Medical School, London. He has served as an Assistant Clinical Professor at Harvard Medical School; on the Scientific Advisory Board of the Armenise-Harvard Foundation and the Publications Committee for the New England Journal of Medicine. His current focus is on natural products for animal and human use, anti-aging strategy, and primitive cell biology. He is an author of more than 40 scientific publications and is the holder of four patents.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.